HOME >> MEDICINE >> NEWS
ACTOS (pioglitazone HCl) significantly improved components of diabetic dyslipidemia

Results from the first head-to-head study between ACTOS and Avandia (rosiglitazone maleate) published in Diabetes Care

Lincolnshire, IL, June 29, 2005 A new study published in today's issue of Diabetes Care demonstrated that ACTOS improved components of diabetic dyslipidemia to a significantly greater extent than Avandia. Specifically, the results indicated that treatment with ACTOS lowered triglycerides (a type of lipid, or fat, found in food and the body), increased HDL-C ("good" cholesterol), and improved LDL-C ("bad" cholesterol) particle concentration and particle size. These differences were independent of blood glucose control and occurred without the use of a traditional lipid-lowering statin medication.

Diabetic dyslipidemia is a condition commonly found in people with type 2 diabetes and is an important risk factor for cardiovascular disease, the leading cause of death for people with type 2 diabetes. Diabetic dyslipidemia is characterized by increased triglycerides and decreased HDL-C. People with diabetic dyslipidemia also tend to have normal levels of LDL-C, but smaller, denser LDL-C particles that are likely to contribute to cholesterol build-up in arteries.

"This study provides important insight into the relative impact of each drug on important cardiovascular risk markers," noted principal investigator Ronald B. Goldberg, M.D., professor of Medicine and Associate Director of the Diabetes Research Institute at the University of Miami Miller School of Medicine. "The results demonstrate a clear difference between ACTOS and Avandia on their effects on diabetic dyslipidemia, with ACTOS lowering triglycerides and raising HDL-C to a greater extent than Avandia."

Study Design

This 24-week prospective, randomized, multicenter, double-blind clinical trial enrolled 802 people with type 2 diabetes (treated with diet alone or oral monotherapy) and dyslipidemia (not treated with any lipid-
'"/>

Contact: Amy Losak
646-935-3917
Ketchum
29-Jun-2005


Page: 1 2 3

Related medicine news :

1. ACTOS (pioglitazone HCl) demonstrates significant improvements in cardiovascular outcomes
2. ACTOS reduces stroke by almost 50 percent
3. ACTOS (pioglitazone HCl) to be studied in new trial
4. New data shows ACTOS reduced heart attacks by 28 percent in people with type 2 diabetes
5. ACTOplus met (pioglitazone HCl and metformin HCl)
6. Trial stops after stroke and mortality significantly reduced by blood
7. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
8. Full-term, low-birth-weight babies at significantly greater risk for early respiratory symptoms
9. Once-yearly treatment significantly reduces bone fractures in women with postmenopausal osteoporosis
10. New study: Pine bark significantly reduces endometriosis
11. Regular acupressure can significantly reduce agitated behavior in dementia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... Want to ... 1, Cerebral Palsy Alliance Research Foundation (CPARF) is thrilled to launch its fourth annual ... research. A fully virtual challenge, STEPtember meets everyone wherever they are at this moment ...
(Date:8/31/2020)... ... 31, 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on ... ways to trim the fat from our monthly expenses and put more into savings, if ... that you have a financial safety net in place in case something were to happen ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde ... for patients with advanced heart failure, today announced that the company has been ... of $555,358 from the National Heart, Lung, and Blood Institute of the National ...
(Date:8/28/2020)... ... August 28, 2020 , ... The ... a customized Lighthouse Health & Wellness mobile app and web-portal. NCPCV received a ... Solutions Foundation awards grants each year to organizations, such as Destination Imagination, which ...
(Date:8/28/2020)... ANGELES (PRWEB) , ... August 28, 2020 , ... ... on international observations that strongly suggest that obese individuals are at an increased ... people are any more likely to catch COVID-19; however, because the same organ ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... and ROCKWALL, Texas (PRWEB) , ... ... ... Powerful Preventative in the Fight Against Covid-19 , Advanced Penetration Technology, LLC, ... innovative healthcare solutions for patients utilizing non-prescription, Over The Counter (OTC) products, ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... appointed to serve as Secretary to the Board of Trustees and committee chair ... High United Way is a Denver-based nonprofit organization that fights for the education, ...
(Date:8/31/2020)... AVIV, Israel (PRWEB) , ... August 31, 2020 ... ... to specialize in wellness-related technologies, today announced that they have invested $400,000 in ... competition that ran in collaboration with the Global Wellness Institute (GWI). , ...
Breaking Medicine Technology:
Cached News: